STOCK TITAN

Longduoduo Co (LDDD) 10-K Filings

LDDD OTC

Here are the 10-K annual reports from Longduoduo Co Ltd (LDDD) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-K covers the audited annual report, with the full financial statements, so if you follow LDDD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LDDD filings page.

Rhea-AI Summary

Longduoduo Company Limited (LDDD) reported fiscal 2026 revenue of $1,822,457, down 57% from the year ended June 30, 2025. Over 99.6% came from commissions on sales for Inner Mongolia Honghai Health Management Co., Ltd.; five sales agency agreements expire June 20, 2029. Principal healthcare-service revenue was $6,539, down almost 95% year over year.

Gross profit was $1,805,499, but operating expenses of $2,438,680 resulted in an operating loss of $633,181 and a net loss of $642,267, versus net income of $492,260 in fiscal 2025. Operating activities used $163,109 cash, compared with $277,365 provided in fiscal 2025. At June 30, 2026, cash and cash equivalents were $1,588,930 and working capital was $501,414. The company reported $790,429 in deferred revenue from customer prepayments and said most deposits had been applied to ongoing expenses, leaving $138,287 in prepayments. Management said it could not assure sufficient operating cash or financing to remain a going concern.

Rhea-AI Summary

Longduoduo Co., Ltd. operates preventive healthcare services in China through a network of third-party providers and consolidated subsidiaries. The company reported positive net income of $492,260 for the year ended June 30, 2025, down from $1,363,278 a year earlier, and operating income declined from $2,026,141 to $552,679. Advertising and promotion expenses decreased to $1,942,661 from $3,338,737, and cash in excess of insured amounts was $1,130,547 at June 30, 2025. The company completed corporate reorganizations and acquisitions of multiple subsidiaries (including LDD, Julong, Yihua) and completed a 1-for-10 reverse stock split in September 2023, leaving 30,015,036 shares outstanding. Significant disclosures include a 100% valuation allowance on deferred tax assets and identified deficiencies in internal controls and accounting expertise.